Your browser doesn't support javascript.
loading
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone.
Dohm, Ammoren E; Tang, Joseph D; Mills, Matthew N; Liveringhouse, Casey L; Sandoval, Maria L; Perez, Bradford A; Robinson, Timothy J; Creelan, Benjamin C; Gray, Jhanelle E; Etame, Arnold B; Vogelbaum, Michael A; Forsyth, Peter; Yu, Hsiang-Hsuan Michael; Oliver, Daniel E; Ahmed, Kamran A.
Affiliation
  • Dohm AE; 1Departments of Radiation Oncology.
  • Tang JD; 1Departments of Radiation Oncology.
  • Mills MN; 1Departments of Radiation Oncology.
  • Liveringhouse CL; 1Departments of Radiation Oncology.
  • Sandoval ML; 1Departments of Radiation Oncology.
  • Perez BA; 1Departments of Radiation Oncology.
  • Robinson TJ; 1Departments of Radiation Oncology.
  • Creelan BC; 2Thoracic Oncology.
  • Gray JE; 2Thoracic Oncology.
  • Etame AB; 3Neurosurgery, and.
  • Vogelbaum MA; 3Neurosurgery, and.
  • Forsyth P; 4Neuro-Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
  • Yu HM; 1Departments of Radiation Oncology.
  • Oliver DE; 1Departments of Radiation Oncology.
  • Ahmed KA; 1Departments of Radiation Oncology.
J Neurosurg ; : 1-8, 2022 Nov 11.
Article in En | MEDLINE | ID: mdl-36681988

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2022 Type: Article